Literature DB >> 26063422

Context-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus Assembly.

Laura A VanBlargan1, Kaitlin A Davis2, Kimberly A Dowd3, David L Akey4, Janet L Smith5, Theodore C Pierson6.   

Abstract

UNLABELLED: The molecular mechanisms that define the specificity of flavivirus RNA encapsulation are poorly understood. Virions composed of the structural proteins of one flavivirus and the genomic RNA of a heterologous strain can be assembled and have been developed as live attenuated vaccine candidates for several flaviviruses. In this study, we discovered that not all combinations of flavivirus components are possible. While a West Nile virus (WNV) subgenomic RNA could readily be packaged by structural proteins of the DENV2 strain 16681, production of infectious virions with DENV2 strain New Guinea C (NGC) structural proteins was not possible, despite the very high amino acid identity between these viruses. Mutagenesis studies identified a single residue (position 101) of the DENV capsid (C) protein as the determinant for heterologous virus production. C101 is located at the P1' position of the NS2B/3 protease cleavage site at the carboxy terminus of the C protein. WNV NS2B/3 cleavage of the DENV structural polyprotein was possible when a threonine (Thr101 in strain 16681) but not a serine (Ser101 in strain NGC) occupied the P1' position, a finding not predicted by in vitro protease specificity studies. Critically, both serine and threonine were tolerated at the P1' position of WNV capsid. More extensive mutagenesis revealed the importance of flanking residues within the polyprotein in defining the cleavage specificity of the WNV protease. A more detailed understanding of the context dependence of viral protease specificity may aid the development of new protease inhibitors and provide insight into associated patterns of drug resistance. IMPORTANCE: West Nile virus (WNV) and dengue virus (DENV) are mosquito-borne flaviviruses that cause considerable morbidity and mortality in humans. No specific antiflavivirus therapeutics are available for treatment of infection. Proteolytic processing of the flavivirus polyprotein is an essential step in the replication cycle and is an attractive target for antiviral development. The design of protease inhibitors has been informed by insights into the molecular details of the interactions of proteases and their substrates. In this article, studies of the processing of WNV and DENV capsid proteins by the WNV protease identified an unexpected contribution of the sequence surrounding critical residues within the cleavage site on protease specificity. This demonstration of context-dependent protease cleavage has implications for the design of chimeric flaviviruses, new therapeutics, and the interpretation of flavivirus protease substrate specificity studies.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26063422      PMCID: PMC4524226          DOI: 10.1128/JVI.01253-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins.

Authors:  B Falgout; M Pethel; Y M Zhang; C J Lai
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Kinetic and modeling studies of S3-S3' subsites of HIV proteinases.

Authors:  J Tözsér; I T Weber; A Gustchina; I Bláha; T D Copeland; J M Louis; S Oroszlan
Journal:  Biochemistry       Date:  1992-05-26       Impact factor: 3.162

3.  Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites.

Authors:  T J Chambers; A Grakoui; C M Rice
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid.

Authors:  S C Pettit; J Simsic; D D Loeb; L Everitt; C A Hutchison; R Swanstrom
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

5.  Studies on the symmetry and sequence context dependence of the HIV-1 proteinase specificity.

Authors:  J Tözsér; P Bagossi; I T Weber; J M Louis; T D Copeland; S Oroszlan
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

6.  Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site.

Authors:  C Lin; S M Amberg; T J Chambers; C M Rice
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

7.  Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3.

Authors:  M Lobigs
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies.

Authors:  S M Amberg; A Nestorowicz; D W McCourt; C M Rice
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Processing and localization of Dengue virus type 2 polyprotein precursor NS3-NS4A-NS4B-NS5.

Authors:  L Zhang; P M Mohan; R Padmanabhan
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites.

Authors:  T W Ridky; C E Cameron; J Cameron; J Leis; T Copeland; A Wlodawer; I T Weber; R W Harrison
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

View more
  10 in total

1.  Role of Capsid Anchor in the Morphogenesis of Zika Virus.

Authors:  Jyoti Rana; José Luis Slon Campos; Gabriella Leccese; Maura Francolini; Marco Bestagno; Monica Poggianella; Oscar R Burrone
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

2.  Dengue Virus Serotype 1 Conformational Dynamics Confers Virus Strain-Dependent Patterns of Neutralization by Polyclonal Sera.

Authors:  Laura A VanBlargan; Pavle S Milutinovic; Leslie Goo; Christina R DeMaso; Anna P Durbin; Stephen S Whitehead; Theodore C Pierson; Kimberly A Dowd
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

3.  Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo.

Authors:  George I Georgiev; Ryan J Malonis; Ariel S Wirchnianski; Alex W Wessel; Helen S Jung; Sean M Cahill; Elisabeth K Nyakatura; Olivia Vergnolle; Kimberly A Dowd; David Cowburn; Theodore C Pierson; Michael S Diamond; Jonathan R Lai
Journal:  Cell Chem Biol       Date:  2022-02-28       Impact factor: 9.039

Review 4.  Tick-Borne Encephalitis Virus: A Structural View.

Authors:  Lauri I A Pulkkinen; Sarah J Butcher; Maria Anastasina
Journal:  Viruses       Date:  2018-06-28       Impact factor: 5.048

5.  Potential Dual Role of West Nile Virus NS2B in Orchestrating NS3 Enzymatic Activity in Viral Replication.

Authors:  Alanna C Tseng; Vivek R Nerurkar; Kabi R Neupane; Helmut Kae; Pakieli H Kaufusi
Journal:  Viruses       Date:  2021-01-31       Impact factor: 5.048

Review 6.  Running With Scissors: Evolutionary Conflicts Between Viral Proteases and the Host Immune System.

Authors:  Brian V Tsu; Elizabeth J Fay; Katelyn T Nguyen; Miles R Corley; Bindhu Hosuru; Viviana A Dominguez; Matthew D Daugherty
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

Review 7.  Structure and function of capsid protein in flavivirus infection and its applications in the development of vaccines and therapeutics.

Authors:  Xingcui Zhang; Yanting Zhang; Renyong Jia; Mingshu Wang; Zhongqiong Yin; Anchun Cheng
Journal:  Vet Res       Date:  2021-06-30       Impact factor: 3.683

8.  Oral Vaccination with a DNA Vaccine Encoding Capsid Protein of Duck Tembusu Virus Induces Protection Immunity.

Authors:  Juan Huang; Haoyue Shen; Renyong Jia; Mingshu Wang; Shun Chen; Dekang Zhu; Mafeng Liu; Xinxin Zhao; Qiao Yang; Ying Wu; Yunya Liu; Ling Zhang; Zhongqiong Yin; Bo Jing; Anchun Cheng
Journal:  Viruses       Date:  2018-04-06       Impact factor: 5.048

9.  DENV2 Pseudoviral Particles with Unprocessed Capsid Protein Are Assembled and Infectious.

Authors:  Jyoti Rana; Oscar R Burrone
Journal:  Viruses       Date:  2019-12-25       Impact factor: 5.048

Review 10.  Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review.

Authors:  Abdul Wahaab; Bahar E Mustafa; Muddassar Hameed; Nigel J Stevenson; Muhammad Naveed Anwar; Ke Liu; Jianchao Wei; Yafeng Qiu; Zhiyong Ma
Journal:  Viruses       Date:  2021-12-28       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.